Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1999 1
2001 1
2002 1
2004 1
2010 2
2012 1
2014 1
2018 1
2019 1
2020 1
2021 1
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Tofacitinib versus methotrexate in rheumatoid arthritis.
Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, Koncz T, Krishnaswami S, Wallenstein GV, Zang C, Zwillich SH, van Vollenhoven RF; ORAL Start Investigators. Lee EB, et al. N Engl J Med. 2014 Jun 19;370(25):2377-86. doi: 10.1056/NEJMoa1310476. N Engl J Med. 2014. PMID: 24941177 Free article. Clinical Trial.
Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study.
Nasonov E, Fatenejad S, Feist E, Ivanova M, Korneva E, Krechikova DG, Maslyanskiy AL, Samsonov M, Stoilov R, Zonova EV, Genovese M. Nasonov E, et al. Among authors: zonova ev. Ann Rheum Dis. 2022 Apr;81(4):469-479. doi: 10.1136/annrheumdis-2021-219876. Epub 2021 Aug 3. Ann Rheum Dis. 2022. PMID: 34344706 Free PMC article. Clinical Trial.
[The efficacy and safety of intra-articular application of a combination of sodium hyaluronate and chondroitin sulfate for osteoarthritis of the knee: a multicenter prospective study].
Alekseeva LI, Kashevarova NG, Taskina EA, Sharapova EP, Anikin SG, Strebkova EA, Raskina TA, Zonova EV, Otteva EN, Rodionova SS, Torgashin AN, Buklemishev UV, Shmidt EI, Shesternya PA, Naumov AV, Zagorodniy NV, Lila AM. Alekseeva LI, et al. Among authors: zonova ev. Ter Arkh. 2020 Jun 5;92(5):46-54. doi: 10.26442/00403660.2020.05.000631. Ter Arkh. 2020. PMID: 32598775 Russian.
Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy).
Karateev AE, Pogozheva EY, Filatova EA, Amirjanova VN, Lila AM, Antipova OV, Babaeva AR, Volkorezova AV, Davydova AF, Davtyan VG, Zonova EV, Ivanova ON, Kalinina NN, Kiseleva NI, Knyazeva LA, Kulikov AI, Nesmeyanova OB, Mazurov VI, Masneva LV, Menshikova LV, Obuhova IV, Otteva EN, Salnikova TS, Shсhendrygin IN, Yakupova SP. Karateev AE, et al. Among authors: zonova ev. Ter Arkh. 2018 Jun 20;90(6):65-73. doi: 10.26442/terarkh201890665-73. Ter Arkh. 2018. PMID: 30701907
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR, O'Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP, Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T, Reginster JY, Rodriguez-Portales JA, Roux C, Zanchetta J, Zerbini CAF, Park JG, Im K, Cange A, Grip LT, Heyden N, DaSilva C, Cohn D, Massaad R, Scott BB, Verbruggen N, Gurner D, Miller DL, Blair ML, Polis AB, Stoch SA, Santora A, Lombardi A, Leung AT, Kaufman KD, Sabatine MS; LOFT Investigators. McClung MR, et al. Lancet Diabetes Endocrinol. 2019 Dec;7(12):899-911. doi: 10.1016/S2213-8587(19)30346-8. Epub 2019 Oct 31. Lancet Diabetes Endocrinol. 2019. PMID: 31676222 Clinical Trial.
13 results